Thursday, June 19th, 2025
Stock Profile: PYPD

PolyPid Ltd. (PYPD)

Market: NASD | Currency: USD

Address: 18 Hasivim Street

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.




📈 PolyPid Ltd. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2023 - $0.033333 - 2023-09-21 - Stock split
Total Amount for 2023: $0.033333


📅 Earnings & EPS History for PolyPid Ltd.


DateReported EPS
2026-05-12 (estimated upcoming)-
2026-02-10 (estimated upcoming)-
2025-11-11 (estimated upcoming)-
2025-11-10 (estimated upcoming)-
2025-08-12 (estimated upcoming)-
2025-08-11 (estimated upcoming)-
2025-05-14-
2025-05-14-0.7
2025-05-05-
2025-02-12-1.09
2024-11-131.22
2024-08-14-1.25
2024-08-13-1.25
2024-05-08-1.37
2024-05-07-1.37
2024-02-14-3.97
2024-02-13-3.97
2023-11-08-3.4
2023-11-07-3.4
2023-08-09-0.13
2023-08-08-0.13
2023-05-10-0.28
2023-05-09-0.28
2023-02-08-0.32
2023-02-07-0.32
2022-11-09-0.48
2022-11-08-0.48
2022-08-10-0.61
2022-08-09-0.61
2022-05-11-0.63
2022-05-10-0.63
2022-02-09-0.71
2022-02-08-0.71
2021-11-10-0.53
2021-11-09-0.53
2021-08-11-0.56
2021-08-10-0.56
2021-05-12-0.47
2021-05-11-0.47
2021-02-10-0.41
2021-02-09-0.41
2020-11-11-0.35
2020-11-10-0.35
2020-08-19-6.37
2020-08-18-6.37
2020-06-29-
2020-06-28-
2020-02-24-
2020-02-23-




📰 Related News & Research


No related articles found for "polypid ltd".